openPR Logo
Press release

Alzheimer's Diagnostics Market to Garner USD 8.4 Bn, Globally, by 2026 at 9.03% CAGR - AXIOM MRC

04-08-2020 05:38 PM CET | Health & Medicine

Press release from: Axiom Market Research & Consulting

Alzheimer's Diagnostics Market - Axiom MRC

Alzheimer's Diagnostics Market - Axiom MRC

Wilmington, April 08, 2020: Axiom Market Research & Consulting(TM) added a report on global alzheimer's diagnostic market which includes study on Type, Diagnostics Test, and End user across various countries of key regions across the globe. The global alzheimer's diagnostic market was projected to grow at a CAGR of 9.03% for the forecast period 2020 to 2026. The global market is estimated and forecasted in terms of revenue (USD Million) generated by the alzheimer's diagnostic market.

Browse for More Details: https://www.axiommrc.com/product/10046-alzheimer-s-disease-diagnostic-market-report

The report analyses the Global Alzheimer's Diagnostic Market based on Type, Diagnostics Test, End User and Geography. The types of Alzheimer's diagnostics diseases are Early-Onset Alzheimer's, Late-Onset Alzheimer's and Familial Alzheimer's disease. These disease diagnoses are conducted by various diagnostics tests including Brain Imaging, Blood Tests etc. The Brain imaging is accessible as Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI), Electroencephalography (EEG) and Positron Emission Tomography (PET) Scan. The major end users of these products are Hospitals, Diagnostic Centers, Clinics and Others etc.

The key companies in the alzheimer's diagnostic market are Axon Neuroscience, Koninklijke Philips N.V., TauRx, Siemens AG, F. Hoffmann La Roche AG, GE Healthcare, Navidea biopharmaceuticals, Treventis Corporation, Eli Lilly, Cognition Therapeutics Inc. and Neuro-Bio Ltd (UK).

Alzheimer's Diagnostics Market Regional Trends:
The North America accounted for the largest market in global alzheimer's diagnostic market which was recorded at around 39% in 2019. Stringent government rules for the reimbursement process and inadequate financial conditions of the patients for the treatment are affecting the growth of alzheimer's diagnostics market in the United States and Canada. Furthermore, the Asia Pacific alzheimer's diagnostic market is anticipated to grow at a fastest growth rate of 9.67% during the forecast period. The primary driver of the alzheimer's diagnostics market in China is the burgeoning rise in the population of the country, which is thereby increasing the aging population. This aging population is vulnerable to diseases like dementia, thus causing a rise in its prevalence across the country, mainly in the semi-urban and rural provinces is anticipate to propel the growth of alzheimer's diagnostic market in Asia Pacific region.

Download Sample Report: https://www.axiommrc.com/requested_sample/10046-alzheimer-s-disease-diagnostic-market-report

Alzheimer's Diagnostics Market Segmental Highlights:
o The North America dominated the alzheimer's diagnostic market in 2019
o The late onset alzheimer's segment is anticipated to rise at a growth rate of 9.03% during the forecast period
o The brain imaging segment dominated the global alzheimer's diagnostic market, by diagnostics test in 2019
o The alzheimer's diagnostic market for hospitals in Asia Pacific is anticipated to grow at a CAGR of 9.37% during projection period

Research Objectives of Alzheimer's Diagnostics Market Report:
o Analyzing the outlook of the market with the recent trends and Porter's five forces analysis.
o Market dynamics, which essentially consider the factors that are impelling the present market scenario, along with growth prospects of the market over the forecast period.
o Market segmentation analysis, including qualitative and quantitative research, incorporating the impact of economic and non-economic aspects.
o Country-level analysis, integrating the demand and supply forces that are influencing the growth of the Alzheimer's diagnostics Market.
o Competitive landscape involving the market share of major players, along with the key strategies adopted for development over the past five years.
o Comprehensive company profiles, covering the product offerings, key financial information, recent developments and strategies employed by the major market players

Other Related Reports:

Autoimmune Disease Diagnosis Market Report:
https://www.axiommrc.com/product/hc2118-autoimmune-disease-diagnosis-market-report

Brain Monitoring Devices Market Report:
https://www.axiommrc.com/product/hc1858-brain-monitoring-devices-market-report

Ganesh Sai
United States
3 Germay Dr.Ste 4 - 4666
Wilmington DE 19804
U.S.:- + 1 (845) 875-9786
U.K.:- + 44 (0) 20 3286 9707
Email: sales@axiommrc.com

Axiom Market Research & Consulting(TM) (also known as Axiom MRC), is a full-service market research and data analytics firm, driven by a simple aim of providing key market intelligence to companies to assist them in taking informed business decisions pertaining to their marketing strategy, investments, new product launches, market competition, consumer or end users, social media trends etc.

Axiom Market Research & Consulting(TM) offers market research and data analytics services such as syndicated market research reports, custom market research reports,business consulting, consumer/end user survey, data processing & analytical services, social media analytics across various industry verticals such as, Life Science, Chemicals & Materials, Food & Beverages, Packaging Agriculture, Power & Energy.

Market research reports are based on scientifically developed statistics and content analytics tool 'Qual-Quant Data Model', in which various industry vertical's qualitative information such as market drivers, restraints, opportunities, market trends, competitive landscapes etc. are tracked and compared. The tool also helps in the extraction of market size and growth rates and compares the value chain of the industry vertical.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Alzheimer's Diagnostics Market to Garner USD 8.4 Bn, Globally, by 2026 at 9.03% CAGR - AXIOM MRC here

News-ID: 2004129 • Views:

More Releases from Axiom Market Research & Consulting

Increasing investments in the development of renewable energy and upgrading of existing metro lines across the globe are expected to fuel the growth of DC Switchgear Industry
Increasing investments in the development of renewable energy and upgrading of e …
DC switchgear Market is anticipated to grow at a CAGR of 5.90% from 2022 to 2029 Switchgear is a group of electrical devices that includes fuses, circuit breakers, and electrical disconnect switches. They are used to protect, monitor, control, and isolate electrical equipment. A DC Switchgear refers to a type of electrical switchgear that is used for direct current (DC) applications. DC Switchgear is used in a variety of DC power
Bioreactors and Fermenters Market Insights, Trends, Outlook, and Opportunity Ana …
Axiom Market Research & Consulting published a report which covers detailed analysis of key drivers and restricting factors, value chain analysis, economic impact of Bioreactors and Fermenters market, GDP impact and competitive landscape backed by strategic outlook of each company. the global Bioreactors and Fermenters market is projected to grow at an impressive CAGR over the forecast period of 2023 to 2029. the global market is estimated and forecasted in
Pharmacy Automation Market Competitive Landscape, Growth Factors and Forecast 2019 to 2028
Pharmacy Automation Market Competitive Landscape, Growth Factors and Forecast 20 …
In the modern healthcare system, the automation in the pharmacy sector plays an important role, as it minimizes the errors during the manual processes including, missing drug information, missing patient information, formulation dispensing, prescription errors, and monitoring therapies. The wrong label instruction and information are major mistakes. As per the National Coordinating council for medication error reporting and prevention (NCC MERP), in U.S. approximately 100 million people die annually from

More Releases for Alzheimer

Dementia - Alzheimer Disease Market: A Comprehensive Analysis 2030
Dementia and Alzheimer's disease represent significant challenges within the global healthcare sector. These neurological disorders, characterized by progressive cognitive decline, have seen increasing prevalence due to aging populations worldwide. This growing burden has spurred interest in the Dementia - Alzheimer's disease market, encompassing diagnostic tools, treatments, caregiving solutions, and related healthcare services. This article provides an overview of the market, its scope, current trends, and factors driving its expansion. Data Bridge
Alzheimer Disease Treatment Market | Allergan, Amgen, Daiichi Sankyo, Eisai
The global alzheimer disease treatment market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the alzheimer disease treatment market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth
United States Alzheimer Drugs Market Insights Deep Analysis 2023-2031
Cognate Life Sciences introduces a report on "United States Alzheimer Drugs Market 2023" with Market Insights Reports, Introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also talks about crucial pockets of the industry such as products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context and more. It conjointly
Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe …
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors is
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,
Global Alzheimer Market Report: 2015 Edition | Now Available at Researchmoz.us
Researchmoz added Most up-to-date research on "Global Alzheimer Market Report: 2015 Edition" to its huge collection of research reports. Alzheimer’s disease is defined as an advanced neurological disorder that increasingly deprives patients of their memory and ability to carry out daily activities. As it grows in a human brain, individuals are likely to practice difficulties in linguistic, agility and insight along with negative changes in the character and performance such as